Treatment GuideJust DiagnosedSex & DatingAfrican AmericanStigmaAsk the HIV DocPrEP En EspañolNewsVoicesPrint IssueVideoOut 100
CONTACTCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2025 Pride Publishing Inc.
All Rights reserved
All Rights reserved
By continuing to use our site, you agree to our Private Policy and Terms of Use.
Gilead Sciences has announced a failed second attempt to craft a one-pill, once-daily regimen containing its anti-HIV drug Truvada with Bristol-Myers Squibb's Sustiva. An initial attempt to craft the one-pill therapy failed in April. Gilead and Roche plan to consider new ways to combine the drugs, including a layering approach. They hope to file for Food and Drug Administration approval of the single-pill treatment in the first half of 2006. __________ Abbott Laboratories has announced that it is working on a new tablet formulation of protease inhibitor Kaletra. The tablet formulation would reduce the pill burden from three to two pills per day and would not have to be refrigerated. __________ Roche and Trimeris have filed for FDA approval to use the Biojector 2000 device to administer the fusion inhibitor Fuzeon. The device uses a carbon dioxide-powered injector to spray liquid medication through the skin, which could reduce injection-site reactions. A decision by the FDA is expected by the end of the year. __________ Switching to Reyataz from other protease inhibitors maintains viral suppression and results in fewer viral rebounds, improved gastrointestinal tolerance, and significant lipid improvements, according to a study presented at the Third International AIDS Society Conference on HIV Pathogenesis and Treatment. __________ Replacing Zerit with Viread can maintain virologic control while decreasing cardiovascular risks by lowering total cholesterol, 'bad' cholesterol, and triglyceride levels, according to a study discussed at the Third International AIDS Society Conference on HIV Pathogenesis and Treatment. __________ A four-nucleoside regimen containing Viread and Trizivir following treatment failure with protease inhibitor- or nonnuke-based regimens is effective in reducing blood-based viral counts to below 400 copies in 87% of adults and to below 50 copies in 59% of adults, according to a study presented at the Third International AIDS Society Conference on HIV Pathogenesis and Treatment. __________ A study discussed at the Third International AIDS Society Conference on HIV Pathogenesis and Treatment has shown that Viread does affect kidney function but rarely causes overt renal failure. __________ The FDA has given fast-track approval designation to the experimental protease inhibitor GSK-640385, being developed by GlaxoSmithKline, based on data from a Phase IIa clinical trial showing the drug was effective against strains of HIV resistant to other protease inhibitors. __________ GlaxoSmithKline launched a final Phase III clinical trial of experimental fusion inhibitor aplaviroc, formerly known as GSK-873140. The drug works by binding CCR5 receptors on the surface of immune system cells, preventing HIV from latching on to them. __________ A six-month Phase II clinical trial of the Incyte experimental nucleoside reverse transcriptase inhibitor Reverset showed the drug reduced HIV viral loads by more than 90% in more than half of all study subjects who had built up resistance to other anti-HIV medications. __________ Phase II trial data for the Tibotec experimental protease inhibitor TMC 114 shows that a Norvir-boosted dose of the medication is effective as the cornerstone of salvage therapy for triple-class-experienced HIV patients, including those resistant to other protease inhibitors. __________ Officials from 26 drug companies and 11 Latin American countries reached a deal in August to slash prices of anti-HIV medications by as much as 66%. The price cuts will remain effective for two years.
From our Sponsors
Most Popular
Lexi Love comes out as HIV+ after Trump deletes federal resources
January 23 2025 11:23 AM
Ricky Martin delivers showstopping performance for 2024 World AIDS Day
December 05 2024 12:08 PM
Trump's orders prompt CDC to erase HIV resources
January 31 2025 5:29 PM
California confirms first case of even more deadly mpox strain
November 18 2024 3:02 PM
This long-term HIV survivor says testosterone therapy helped save his life.
December 16 2024 8:00 PM
Plus: Featured Video
Latest Stories
HRC holds 'die-in' to protest Trump health care cuts
April 28 2025 2:11 PM
Two right-wing Supreme Court justices signal they may uphold access to PrEP and more
April 21 2025 4:10 PM
500,000 Children at Risk: PEPFAR Funding Crisis
April 08 2025 3:51 PM
Broadway's best raise over $1 million for LGBTQ+ and HIV causes
April 03 2025 7:15 PM
The Talk Season 5 premieres this spring with HIV guidance for the newly diagnosed
March 26 2025 1:00 PM
Discover the power of Wellness in your life
March 26 2025 12:41 PM
Season 4 of The Switch on resilience & radical self-love returns this spring
March 26 2025 12:20 PM
Jess King is here to help you live your happiest, healthiest life yet
March 24 2025 4:35 PM
BREAKING NEWS: Trump admin moves to end federal HIV prevention programs
March 18 2025 6:10 PM
Gerald Garth is keeping people of color happy and healthy through trying times
March 11 2025 3:38 PM
Celebrating Black History Month with our annual African American issue
February 01 2025 3:28 PM
Tyler TerMeer vows to continue to fight for health care for all
January 28 2025 3:00 PM
Plus nominated for 2025 GLAAD Media Award
January 22 2025 12:42 PM
A camp for HIV-positive kids is for sale. Here's why its founder is celebrating
January 02 2025 12:21 PM
'RuPaul's Drag Race' star Trinity K Bonet quietly comes out trans
December 15 2024 6:27 PM
AIDS Memorial Quilt displayed at White House for the first time
December 02 2024 1:21 PM
Decades of progress, uniting to fight HIV/AIDS
December 01 2024 12:30 PM
Hollywood must do better on HIV representation
December 01 2024 9:00 AM
Climate change is disrupting access to HIV treatment
November 25 2024 11:05 AM
Post-election blues? Some advice from mental health experts
November 08 2024 12:36 PM